Feb 16, 2023 / 07:20PM GMT
Roanna Ruiz - SVB Securities LLC - Analyst
Great. Welcome back everyone to our next session. I'm Roanna Ruiz, Senior Biotech Analyst here at SVB Securities, and it's my pleasure to introduce the management team of ARS Pharmaceuticals.
First we have Richard Lowenthal, CEO; and Eric Karas, Chief Commercial Officer. So thanks both for joining us. And we're going to kick it off a little bit with some bigger picture questions. So maybe, could you just give us a brief overview of the company and your lead intranasal epinephrine product, neffy?
Richard Lowenthal - ARS Pharmaceuticals, Inc. - President & CEO
Yes. Thank you, Roanna. So we started ARS a number of years ago, really, with the explicit focus of developing needle-free nasal spray with epinephrine that can achieve injection-like levels, therapeutic levels of epinephrine to solve a lot of problems in the community.
And at the time, we are working on a number of other nasal spray products that we're proud to have been involved in and are on the market. And we're also working with the
ARS Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 17, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers